GPs offered access to antibody testing from next week

GPs will be able to request COVID-19 antibody tests for themselves and patients from next week, the government has announced.

Health and social care secretary Matt Hancock (Photo: Tolga Akmen/AFP/Getty Images)
Health and social care secretary Matt Hancock (Photo: Tolga Akmen/AFP/Getty Images)

Speaking at a coronavirus briefing on 21 May, health secretary Matt Hancock revealed plans for a national antibody testing programme after the government secured a deal for 10m tests.

Tests will be prioritised for NHS and care staff, and clinicians will be able to request them for patients both in hospital and in social care settings.

Antibody testing will confirm whether people have previously had the virus, while swab testing carried out to date as part of the UK response to the pandemic confirms current infection.

Antibody tests

Mr Hancock said antibody testing would be rolled out 'in a phased way' from next week. He added: 'This is an important milestone and it represents further progress in our national testing programme. Knowing you have these antibodies will help us to understand in the future if you are at lower risk of catching coronavirus, dying from coronavirus and of transmitting coronavirus.’

The health secretary also revealed that three further tests were being assessed.

Healthcare staff will be asked by their employer if they want to have an antibody test, with NHS England setting up a network of regional CEOs to oversee the work. Patients who are already having blood taken as part of other tests will be asked whether they would like an antibody test.

As part of the Public Health England’s (PHE) SIREN study, which will investigate whether antibodies indicate immunity to covid-19, 10,000 healthcare workers will be studied for at least a year.

COVID-19 infection

Data will be collected on their history of infection and any new symptoms they present and individuals will have nose and throat swabs and blood samples taken regularly.

SIREN study lead Dr Susan Hopkins, said: ‘ The results of this PHE study will be an important piece of the puzzle. We know people who have had COVID-19 produce antibodies in response but what we don’t know is whether this means they have immunity against future infection and how long that protection may last. Improving our understanding will be critical to future decisions about how best to control the spread of coronavirus.’

Earlier this month RCGP chair Professor Martin Marshall called on the government to shift away from 'arbitrary numbers and targets', and focus on wider access to testing for health professionals and the public. He also said it was essential that GPs had access to testing to protect patients in care homes.

Swab testing was extended to asymptomatic GPs, care home residents and staff at the end of April after originally being provided to symptomatic GPs and their families in mid-April.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Most children could be removed from shielded patient list, deputy CMO suggests

Most children could be removed from shielded patient list, deputy CMO suggests

Most children could be removed from the shielded patient list in a future wave of...

GPs can provide some care for shielded patients in clinical settings, NHS England confirms

GPs can provide some care for shielded patients in clinical settings, NHS England confirms

GPs can provide care to shielded patients in 'infection-controlled clinical settings'...

How digital assistants can help patients manage their health and wellbeing

How digital assistants can help patients manage their health and wellbeing

A project in Staffordshire has shown how practices can make use of digital technology...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Fair death-in-service deal for locums vital before second COVID-19 wave, warns BMA

Fair death-in-service deal for locums vital before second COVID-19 wave, warns BMA

The government must do ‘the right thing’ and secure adequate death-in-service benefits...

GP workload fears over antibody testing rollout for 'no clinical benefit'

GP workload fears over antibody testing rollout for 'no clinical benefit'

GP practices are being contacted by patients asking for antibody tests as the government...